|
|
|
Session 4: New Drug Development of Cancer /Tumors and Leukaemia
|
|
Title: Taxane-Based Tumor-Targeting Anticancer Agents
Dr. Iwao Ojima, Distinguished Professor and Director, Institute of Chemical Biology & Drug Discovery (ICB&DD), The Chemistry Building, State University of New York at Stony Brook, USA |
|
Title: Drug Resistance Mediated by Steroid Hormones: Mechanisms and New Opportunity for Drug Development
Dr. Weimin Fan , Professor of Pathology and Medicine, Member, Hollings Cancer Center, Medical University of South Carolina, USA
|
|
Title: Production Technology for New Emerging Drugs and the Challenges and Strategies During Technology-transfer, Up-scaling and Implementation
Dr. Jochen Urthaler, Boehringer Ingelheim, Austria
|
|
Title: Molecular Oncology and Targeted Cancer Therapy
Dr. Weikang Tao, Department of Cancer Research, Merck Research Laboratories, USA
|
| |
Title: Profiling Autoantibodies In Lung Cancer: A Diagnostic Approach for Early Stage and Pre-diagnosed Lung Cancer
Dr. Li Zhong , University of Kentucky College of Medicine, USA
|
|
Title: Identifying Clinically Significant Tumor Cell Surface Antigens by Phage Antibody Display and Laser Capture Microdissection
Dr. Bin Liu , Assistant Professor, Department of Anesthesia, UCSF Comprehensive Cancer Center, USA
|
|
Title: Animal models and Drug Design for Therapy of Met-Triggered Cancers
Dr. Flavio Maina, Developmental Biology Institute of Marseille (IBDM), France
|
|
Title: The Diagnosis of Primary Brain Tumors Based on the Study of Stereotactic Biopsies by 1H NMR
Dr. Pr Myriam Malet-Martino, Groupe de RMN Biom¨¦dicale, Laboratoire SPCMIB (UMR CNRS 5068), Universit¨¦ Paul Sabatier, France
|
|
Title: Vitamin Succinate As a Therapy for erbB2-Over-Expressing Breast Cancer
Dr. Lanfeng Dong, Apoptosis Research Group, School of Medical Science, Griffith University, Southport, Qld, Australia |
| |
Title: Genetic Alterations in Head and Neck Cancer Cell Lines and Mutations Related to the Chemosensitivity
Dr. Nobuo Tsuchida, Professor and Chairman , Department of Molecular Cellular Oncology and Microbiology, Tokyo Medical and Dental University, Japan
|
|
Title: Comprehensive And Promising Projects Using 5,340 Cdnas Obtained From Primary Neuroblastomas: Successful Establishment Of Commercially Available Cdna Mini-Chips To Predict The Cancer Prognosis And A Feasible Drug Discovery For Neurodegenerative Diseases
Dr. Akira Nakagawara, Director, Chiba Cancer Center Research Institute, Chiba Cancer Center, Professor, Department of Molecular Biology and Oncology, Chiba University School of Medicine, Japan
|
| |
Title: Computational Models of Cancer Therapy and Drug Resistance
Dr. Dominik Wodarz, Department of Ecology and Evolution, University of California, USA |
|
Title: Aminoglycoside-induced correction of APC function in colorectal cancer cells
Dr. Rina Arbesfeld , Tel-Aviv University, Israel |
|
Title: A New Infrared Fluorescent-labeling Agent and Labeled Antibody for Diagnosing Micro-cancer
Dr. Naoki Muguruma , The University of Tokushima Graduate School, Japan |
|
Title: A Human Tumor Genome Project: From Sequence to Structure, Function and possible Drug Discovery
Dr. Colin Collins , UCSF Comprehensive Cancer Center, San Francisco, CA, USA |
| |
Title:Basic Study on Cancer Factors
Dr. Xiaokun Li , Dean of Biology Technical Institute, Jilin Agriculture University, China |
|
Title: Hypoxia inducible factor-1 as a rationalized co-target for epidermal growth factor
receptor-targeted cancer therapy
Dr. Zhen Fan, Associate Professor of Medicine, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, USA |
|
Title: Using Tissue Biospecimens for Biomarker Discovery Research: Collection, Storage, Processing and other Pre-analytical Considerations
Dr. Jeffry Simko , Assistant Professor, Department of Pathology, UCSF, USA |
|
|
Home
